March 24, 2020
RegMed Investors’ (RMi) pre-open: optimism inspires stability and possible some sustainability
March 19, 2020
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector rises like the mythological phoenix
March 17, 2020
RegMed Investors’ (RMi): a stressed market and sector rebounds
March 16, 2020
RegMed Investors’ (RMi): a session of dealing with unknowns and uncertainty
March 12, 2020
RegMed Investors’ (RMi): the sector was surrounded by strong winds in the eye of the storm
March 10, 2020
RegMed Investors’ (RMi) pre-open: back in the game of pick-up-stocks
February 28, 2020
RegMed Investors’ (RMi) pre-open: markets are still spooked
February 18, 2020
RegMed Investors’ (RMi) closing bell: today is a call for investors to categorize the market and sector’s undercurrents
February 13, 2020
RegMed Investors’ (RMi) closing bell: small volume defines the drop of the 20 downsizers
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.